World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Hungary
2025

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
7300
World Ranking
14718
National Ranking
24

Research.com Recognitions

  • 2025 - Research.com Biology and Biochemistry in Hungary Leader Award

Overview

Gabor Halmos is affiliated with the University of Debrecen in Hungary and has an active research profile spanning multiple disciplines within medicine and molecular biology.

Their work broadly covers key fields such as Medicine and Biochemistry, Genetics and Molecular Biology. More specialized subfields include Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Radiology, Nuclear Medicine and Imaging, and Neurology.

Research topics frequently addressed by Gabor Halmos encompass Growth Hormone and Insulin-like Growth Factors, Neuroblastoma Research and Treatments, Peptidase Inhibition and Analysis, Radiopharmaceutical Chemistry and Applications, Ocular Oncology and Treatments, melanin and skin pigmentation, as well as Neuroendocrine Tumor Research Advances.

The scientist has collaborated frequently with several coauthors, including:

  • Zsuzsanna Szabó
  • Éva Juhász
  • Andrew V. Schally
  • József Király
  • Erzsébet Szabó

Publication venues show a focus on journals related to molecular sciences and biomedicine. The most common venues include:

  • Molecules
  • International Journal of Molecular Sciences
  • Biomedicines
  • Life
  • Peptides

Notable recent papers authored or coauthored by Gabor Halmos cover diverse biomedical research topics, such as:

  • "Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity," 2021, Peptides
  • "Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways," 2023, Molecules
  • "Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches," 2022, Molecules
  • "Signaling mechanism of growth hormone-releasing hormone receptor," 2023, Vitamins and hormones
  • "The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma," 2020, Oncotarget

Best Publications

  • Hypothalamic Hormones and Cancer

    Andrew V. Schally;Andrew V. Schally;Ana Maria Comaru-Schally;Ana Maria Comaru-Schally;Attila Nagy;Attila Nagy;Magdolna Kovacs;Magdolna Kovacs

  • The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy.

    Lilla Hornyák;Nikoletta Dobos;Gábor Koncz;Zsolt Karányi

  • Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

    Attila Nagy;Andrew V. Schally;Andrew V. Schally;Patricia Armatis;Karoly Szepeshazi;Karoly Szepeshazi

  • Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

    Attila Nagy;Andrew V. Schally;Andrew V. Schally;Gábor Halmos;Patricia Armatis

  • Peptide analogs in the therapy of prostate cancer

    Andrew V. Schally;Ana Maria Comaru-Schally;Ana Maria Comaru-Schally;Artur Plonowski;Artur Plonowski;Attila Nagy;Attila Nagy

  • The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues

    Alexandre Havt;Andrew V. Schally;Gabor Halmos;Jozsef L. Varga

  • Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

    Attila Nagy;Patricia Armatis;Ren Zhi Cai;Ren Zhi Cai;Karoly Szepeshazi;Karoly Szepeshazi

  • Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone

    M Zarandi;J E Horvath;J E Horvath;G Halmos;J Pinski

  • Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing Hormone

    Masahiro Miyazaki;Attila Nagy;Andrew V. Schally;Andrew V. Schally;Najib Lamharzi

  • Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities

    József L. Varga;Andrew V. Schally;Valér J. Csernus;Valér J. Csernus;Márta Zarándi

  • RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases

    László Halász;Zsolt Karányi;Beáta Boros-Oláh;Tímea Kuik-Rózsa

  • Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Human Prostate Cancer

    Gabor Halmos;Andrew V. Schally;Tamas Czompoly;Magdalena Krupa

  • New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs

    A. V. Schally;K. Szepeshazi;A. Nagy;A. M. Comaru-Schally

  • LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.

    Ferenc G. Rick;Andrew V. Schally;Andrew V. Schally;Norman L. Block;Norman L. Block;Gabor Halmos;Gabor Halmos;Gabor Halmos

  • Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone.

    Ioulia Chatzistamou;Andrew V Schally;Andrew V Schally;Jozsef L Varga;Jozsef L Varga;Kate Groot

  • Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095

    M Miyazaki;M Miyazaki;N Lamharzi;N Lamharzi;A.V Schally;A.V Schally;G Halmos;G Halmos

  • Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice

    Jacek Pinski;Jacek Pinski;Gabor Halmos;Gabor Halmos;Andrew V. Schally;Andrew V. Schally

  • Inhibition of growth of human small cell and non-small cell lung carcinomas by antagonists of growth hormone-releasing hormone (GH-RH).

    Jacek Pinski;Andrew V. Schally;Andreas Jungwirth;Kate Groot

  • Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.

    Renzhi Cai;Andrew V. Schally;Tengjiao Cui;Luca Szalontay

  • A targeted cytotoxic somatostatin (SST) analogue, AN-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice.

    H. Kiaris;A.V. Schally;A.V. Schally;A. Nagy;A. Nagy;K. Szepeshazi;K. Szepeshazi

Frequent Co-Authors

Andrew V. Schally
Andrew V. Schally Veterans Health Administration
Awtar Krishan
Awtar Krishan University of Miami
David G. Bostwick
David G. Bostwick Bostwick Laboratories
Kenneth J. O'Byrne
Kenneth J. O'Byrne Queensland University of Technology
Éva Rajnavölgyi
Éva Rajnavölgyi University of Debrecen
Murray F. Brennan
Murray F. Brennan Memorial Sloan Kettering Cancer Center
Jason Roszik
Jason Roszik The University of Texas MD Anderson Cancer Center
Janardan K. Reddy
Janardan K. Reddy Northwestern University
Young S. Kim
Young S. Kim University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gabor Halmos

Trending Scientists